Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2

Annals of Neurology

Volumn 71, Issue 3, 2012, Pages 370-384

  Pankratz, Nathan ^a   Beecham, Gary W ^b   Destefano, Anita L ^c,d   Dawson, Ted M ^e   Doheny, Kimberly F ^e   Factor, Stewart A ^f   Hamza, Taye H ^g   Hung, Albert Y ^h,i   Hyman, Bradley T ^h,j   Ivinson, Adrian J ^j   Krainc, Dmitri ^h,i   Latourelle, Jeanne C ^c   Clark, Lorraine N ^k   Marder, Karen ^k   Martin, Eden R ^b   Mayeux, Richard ^k   Ross, Owen A ^l   Scherzer, Clemens R ^j,m,n   Simon, David K ⁱ   Tanner, Caroline ^o   Vance, Jeffery M ^b   Wszolek, Zbigniew K ^l   Zabetian, Cyrus P ^p   Myers, Richard H ^c   Payami, Haydeh ^g   Scott, William K ^b   Foroud, Tatiana ^a   more..

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f EMORY UNIVERSITY   (United States)

^g WADSWORTH CENTER   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j The Harvard Center for Neurodegeneration & Repair   (United States)

^k College of Physicians and Surgeons ^*  (United States)

^l MAYO CLINIC   (United States)

^m Partners Parkinson Center   (United States)

ⁿ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^o PARKINSON S INSTITUTE   (United States)

^p UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GAK PROTEIN; HLA ANTIGEN; MAPT PROTEIN; MEMBRANE PROTEIN; RIT2 PROTEIN; SNCA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 18; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; META ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; GLYCOPROTEINS; HUMANS; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84859199353     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22687     Document Type: Article

References (25)

1. de Lau LM, Breteler MM,. Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5: 525-535.
2. Bekris LM, Mata IF, Zabetian CP,. The genetics of Parkinson disease. J Geriatr Psychiatry Neurol 2010; 23: 228-242.
3. Maraganore DM, de Andrade M, Lesnick TG, et al. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 2005; 77: 685-693.
4. Fung HC, Scholz S, Matarin M, et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2006; 5: 911-916.
5. Pankratz N, Wilk JB, Latourelle JC, et al. Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 2009; 124: 593-605.
6. Simõn-Sánchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009; 41: 1308-1312.
7. Edwards TL, Scott WK, Almonte C, et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 2010; 74: 97-109.
8. Hamza TH, Zabetian CP, Tenesa A, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010; 42: 781-785.
9. Saad M, Lesage S, Saint-Pierre A, et al. Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet 2011; 20: 615-627.
10. UK Parkinson's Disease Consortium; Wellcome Trust Case Control Consortium, 2;, Spencer CC, Plagnol V, Strange A, et al. Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet 2011; 20: 345-353.
11. International Parkinson Disease Genomics Consortium;, Nalls MA, Plagnol V, Hernandez DG, et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011; 377: 641-649.
12. Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009; 41: 1303-1307.
13. International Parkinson's Disease Genomics Consortium (IPDGC); Wellcome Trust Case Control Consortium 2 (WTCCC2). A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 2011; 7: e1002142.
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ,. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55; 181-184.
15. Li Y, Willer CJ, Ding J, et al. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010; 34: 816-834.
16. Fan JB, Chee MS, Gunderson KL,. Highly parallel genomic assays. Nat Rev Genet 2006; 7: 632-644.
17. Gibb WR, Lees AJ The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
18. Gao X, Starmer J, Martin ER,. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 2008; 32: 361-369.
19. Lee CH, Della NG, Chew CE, Zack DJ,. Rin, a neuron-specific and calmodulin-binding small G-protein, and Rit define a novel subfamily of ras proteins. J Neurosci 1996; 16: 6784-6794.
20. Lee D, Lee SY, Lee EN, et al. alpha-Synuclein exhibits competitive interaction between calmodulin and synthetic membranes. J Neurochem 2002; 82: 1007-1017.
21. Padilla R, Maccioni RB, Avila J,. Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau. Mol Cell Biochem 1990; 97: 35-41.
22. Bossers K, Meerhoff G, Balesar R, et al. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 2009; 19: 91-107.
23. Nichols WC, Pankratz N, Marek DK, et al.; Parkinson Study Group-PROGENI Investigators. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology 2009; 72: 310-316.
24. Pankratz N, Nichols WC, Elsaesser VE, et al.; Parkinson Study Group-PROGENI Investigators. Alpha-synuclein and familial Parkinson's disease. Mov Disord 2009; 24: 1125-1131.
25. Mata IF, Shi M, Agarwal P, et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch Neurol 2010; 67: 1350-1356.